Form 4 for LUNG Pulmonx Corp
Accepted 2022-11-14 00:00:00 ET · period of report 2022-11-14 · accession 0001209191-22-056872 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-14 | 2022-11-14 | LUNG | Sung Derrick | CFO | M - OptEx | $2.20 | +10.0K | 263.8K | +4% | +$22.0K |
| D | 2022-11-14 | 2022-11-14 | LUNG | Sung Derrick | CFO | M - OptEx | $0.00 | -10.0K | 5,000 | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-14 | M | A | 10,000 | $2.20 | 263,815 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-11-14 | M | D | 10,000 | $0.00 | 5,000 | D | $2.20 · — to 2030-08-27 | 10,000 Common Stock | (F1) The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on August 28, 2020, subject to the Reporting Person's continuous service through each such vesting date. |